Safety and Efficacy of Flecainide in Subjects with Long QT‐3 Syndrome (ΔKPQ Mutation): A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Background: We conducted a study of chronic therapy with flecainide versus placebo in a small group of LQT‐3 patients with the ΔKPQ deletion to evaluate the safety and efficacy of flecainide in this genetic disorder. In vitro studies have shown that flecainide provides correction of the impaired ina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Noninvasive Electrocardiol
Main Authors: Moss, Arthur J., Windle, John R., Hall, W. Jackson, Zareba, Wojciech, Robinson, Jennifer L, McNitt, Scott, Severski, Patricia, Rosero, Spencer, Daubert, James P., Qi, Ming, Cieciorka, Michael, Manalan, Allan S.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing, Inc. 2005
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6932190/
https://ncbi.nlm.nih.gov/pubmed/16274417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1542-474X.2005.00077.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados